Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

Medtronic, which develops, manufactures and sells medical therapy devices, has issued a voluntary recall of its MiniMed 600 series or 700 series insulin pumps due to the pump's potentially shortened ...

The US Food and Drug Administration issued a warning on Thursday about possible risk of hacking for some diabetes patients' insulin pumps. Certain insulin pumps from Medtronic MiniMed have been ...

Medtronic is warning of a potential safety risk involving its MiniMed insulin pumps that has led to at least one hospitalization and one death, according to the Star Tribune. Medtronic said its ...

Please provide your email address to receive an email when new articles are posted on . All Medtronic MiniMed 600 and 700 series insulin pumps have been recalled due to an increased risk for short ...

GRAND RAPIDS, Mich. — Medtronic is recalling MiniMed insulin pumps for incorrect insulin dosing which according to the FDA, can cause serious injury or death. The FDA says this is a class 1 recall, ...

Medtronic has recalled a line of MiniMed Insulin Pumps, with the FDA calling it a Level 1 recall, its most serious level of recall. The FDA said that the use of these devices "may cause serious ...

Medtronic is recalling about 322,000 of its MiniMed insulin pumps due to a malfunction that has led to more than 2,000 injuries and one death, the Food and Drug Administration (FDA) announced ...

Medtronic plc (NYSE:MDT) initiated a recall Friday to address potential battery life issues with its insulin pumps. As of July 31, the company has advised customers to pay close attention to their ...

The FDA announced an international Class 1 recall of 322,005 Medtronic’s MiniMed 600 Series Insulin Pumps that can cause the user to receive an incorrect amount of insulin. According to the recall ...

Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart insulin pens with a glucose sensor made by Abbott.